-
A consensus group making recommendations on the use of restraining therapies in the ICU emphasizes the inadequacy of the evidence base in this area and calls for studies to generate better data.
-
A once-a-day dose of a valacyclovir reduces the rate of transmission of genital herpes (HSV-2) from an infected partner to an uninfected susceptible partner, according to a new study.
-
Clinicians should become confident in management of constipation for numerous reasons, not the least of which is the sheer magnitude of its prevalence in the ambulatory setting.
-
-
-
The first head-to-head comparison study of an ACE inhibitor and an angiotensin receptor blocker, to assess renoprotective effects in type 2 diabetes, has shown that the drugs are comparable in their benefit.
-
-
This article summarizes the major findings of the United States Public Health Service guideline: Treating Tobacco Use and Dependence, a comprehensive, evidence-based strategy for treating tobacco dependence. It also provides recommendations for delivering effective clinical interventions to treat tobacco dependence in the primary care setting including behavioral therapies, first-line medications, and second-line medications. The article concludes with updated information about new medications under development.
-
-
The British government will soon allow over-the-counter (OTC) sales of Mercks simvastatin (Zocor), marking the first time any country has allowed the OTC sale of a statin.
